Barclays raised the firm’s price target on Boston Scientific (BSX) to $118 from $111 and keeps an Overweight rating on the shares. The firm updated the company’s projections to get in line with management’s organic growth outlook.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific price target raised to $122 from $119 at Raymond James
- Boston Scientific price target raised to $120 from $110 at Truist
- Boston Scientific price target raised to $115 from $100 at Stifel
- Boston Scientific price target raised to $120 from $112 at Baird
- Boston Scientific price target raised to $117 from $101 at Canaccord